For the quarter ending 2026-03-31, IPSC had -$11,254K decrease in cash & cash equivalents over the period. -$25,846K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -21,645 | -19,171 | -34,428 | 44,019 |
| Depreciation | 3,004 | 3,550 | 3,129 | 6,422 |
| Non-cash operating lease expense (benefit) | 412 | 427 | 517 | 968 |
| Stock based compensation | 1,445 | 1,300 | 892 | 4,648 |
| Impairment | - | 0 | 6,763 | - |
| Accretion of investments | 211 | 349 | 507 | 1,501 |
| Change in fair value of contingent liabilities | 1,818 | 4,919 | -240 | -145 |
| Gain on reduction in lease liability due to lease termination | - | 0 | 1,395 | - |
| Deferred tax (benefit) expense | - | -73 | - | - |
| Prepaid expenses and other assets | 62 | -1,321 | -585 | -436 |
| Operating lease liability | -786 | -1,399 | -1,232 | -2,347 |
| Deferred revenue | - | 0 | 0 | -109,164 |
| Accounts payable | -1,625 | 2,157 | -591 | -4 |
| Accrued expenses and other liabilities | -3,956 | 1,079 | 443 | -5,837 |
| Security deposit | -20 | - | - | - |
| Net cash used in operating activities | -25,262 | -16,077 | -25,584 | -62,215 |
| Acquisition of property and equipment | 584 | -139 | 195 | 792 |
| Acquisition of fixed maturity securities, available for sale | 140,691 | 15,599 | 11,023 | 24,552 |
| Sale of fixed maturity securities, available for sale | 28,660 | 37,821 | 35,889 | 85,813 |
| Net cash provided (used in) by investing activities | -112,615 | 22,361 | 24,671 | 60,469 |
| Proceeds from issuance of common stock and espp | 202 | 53 | 0 | 120 |
| Proceeds from pipe, net of issuance costs | 126,421 | - | - | - |
| Net cash provided by financing activities | 126,623 | 53 | 0 | 120 |
| Net decrease in cash, cash equivalents, and restricted cash | -11,254 | 6,337 | -913 | -1,626 |
| Cash, cash equivalents and restricted cash, beginning of period | 65,011 | 58,674 | 61,213 | - |
| Cash, cash equivalents and restricted cash, end of period | 53,757 | 65,011 | 58,674 | - |
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)